Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
International Journal of Radiation Oncology, Biology, Physics
|
April 6, 2023
Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
Trudy C Wu, Annalise Stube, Carol Felix, et al.
Gynecologic Oncology
|
January 11, 2024
Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial
Claire F Friedman, Anishka D'Souza, Diana Bello Roufai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2013
A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer
Mark A Socinski, Jonathan Goldman, Iman El-Hariry, et al.
Gynecologic Oncology
|
July 30, 2020
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
Ana Oaknin, Claire F Friedman, Lynda D Roman, et al.
JTO Clinical and Research Reports
|
June 29, 2026
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial
Nicolas Girard, Jonathan Goldman, Shun Lu, et al.
JAMA Oncology
|
April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
Fiamma Berner, David Bomze, Stefan Diem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2024
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous <i>EGFR</i>-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial
D Ross Camidge, Jair Bar, Hidehito Horinouchi, et al.
Chest
|
November 14, 2025
Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer
Sara Sakowitz, Haley I Tupper, Lawrence N Benjamin, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
International Journal of Radiation Oncology, Biology, Physics
|
April 6, 2023
Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
Trudy C Wu, Annalise Stube, Carol Felix, et al.
Gynecologic Oncology
|
January 11, 2024
Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial
Claire F Friedman, Anishka D'Souza, Diana Bello Roufai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2013
A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer
Mark A Socinski, Jonathan Goldman, Iman El-Hariry, et al.
Gynecologic Oncology
|
July 30, 2020
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
Ana Oaknin, Claire F Friedman, Lynda D Roman, et al.
JTO Clinical and Research Reports
|
June 29, 2026
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial
Nicolas Girard, Jonathan Goldman, Shun Lu, et al.
JAMA Oncology
|
April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
Fiamma Berner, David Bomze, Stefan Diem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2024
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous <i>EGFR</i>-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial
D Ross Camidge, Jair Bar, Hidehito Horinouchi, et al.
Chest
|
November 14, 2025
Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer
Sara Sakowitz, Haley I Tupper, Lawrence N Benjamin, et al.
Page
of 4